Kangchen Pharmaceutical: Shareholders intend to reduce their holdings by no more than 2.103 million shares Kangchen Pharmaceutical: Shareholders intend to reduce their holdings by no more than 2.103 million shares

China Securities Network News (reporter Yang Peng) Kangchen Pharmaceutical (603590) announced on the evening of November 2 that gl GLEE Investment Hong Kong Limited, a shareholder of the company, plans to reduce its holdings in the company by a total of no more than 2.103 million shares, that is, no more than 1.31% of the company's total share capital, through centralized auction transactions and block transactions within 6 months after 3 trading days from the date of announcement disclosure.